SCHEMBL23927238

SCHEMBL23927238

Cc1nc(Nc2ncc(C(=O)NC3=C[SH](F)C=C3Cl)s2)cc(N2CCN(CCO)CC2)n1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 14/20 0.71
SIK2 Q9H0K1 13/20 0.71
SIK3 Q9Y2K2 13/20 0.71
SIK1 P57059 11/20 0.71
PKMYT1 Q99640 3/20 0.70
SRC P12931 5/20 0.68
BCR P11274 4/20 0.68
KIT P10721 3/20 0.68
EPHB6 O15197 2/20 0.68
EGFR P00533 2/20 0.68
LCK P06239 2/20 0.68
FYN P06241 2/20 0.68
CSF1R P07333 2/20 0.68
YES1 P07947 2/20 0.68
LYN P07948 2/20 0.68
RET P07949 2/20 0.68
HCK P08631 2/20 0.68
BRAF P15056 2/20 0.68
EPHA1 P21709 2/20 0.68
EPHA2 P29317 2/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28528544 0.84 SIK2 (0.80) ABL1SIK2SIK3SIK1PKMYT1
SCHEMBL21875009 0.83 SIK2 (1.00) ABL1SIK2SIK3SIK1PKMYT1
SCHEMBL21875057 0.83 ABL1 (1.00) ABL1SIK2SIK3SIK1PKMYT1
SCHEMBL1704876 0.83 ABL1 (0.92) ABL1SIK2SIK3SIK1PKMYT1
SCHEMBL31307345 0.82 SIK2 (1.00) ABL1SIK2SIK3SIK1PKMYT1
SCHEMBL31634941 0.82 PKMYT1 (1.00) ABL1SIK2SIK3SIK1PKMYT1
SCHEMBL28430772 0.82 ABL1 (0.83) ABL1SIK2SIK3SIK1PKMYT1
SCHEMBL24098408 0.82 SIK2 (1.00) ABL1SIK2SIK3SIK1PKMYT1
SCHEMBL18231278 0.82 PKMYT1 (1.00) ABL1SIK2SIK3SIK1PKMYT1
SCHEMBL20537113 0.82 ABL1 (0.74) ABL1SIK2SIK3SIK1PKMYT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3901151-A1 HALOGENATED-HETEROARYL AND OTHER HETEROCYCLIC KINASE INHIBITORS, AND USES THEREOF iOmx Therapeutics AG (DE) 2021-10-27 EP disclosed